Lagoda Investment Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-98,575
| Closed | -$2.39M | – | 40 |
|
|
2017
Q1 | $2.39M | Sell |
98,575
-94,938
| -49% | -$2.3M | 0.93% | 17 |
|
|
2016
Q4 | $6.21M | Sell |
193,513
-44,263
| -19% | -$1.42M | 2.13% | 15 |
|
|
2016
Q3 | $11.9M | Sell |
237,776
-47,447
| -17% | -$2.37M | 3.57% | 15 |
|
|
2016
Q2 | $12.1M | Sell |
285,223
-10,615
| -4% | -$450K | 4.51% | 10 |
|
|
2016
Q1 | $19.5M | Buy |
295,838
+14,708
| +5% | +$969K | 6.38% | 8 |
|
|
2015
Q4 | $17.5M | Sell |
281,130
-18,516
| -6% | -$1.15M | 4.63% | 10 |
|
|
2015
Q3 | $20.1M | Buy |
299,646
+32,718
| +12% | +$2.19M | 5.86% | 7 |
|
|
2015
Q2 | $26M | Buy |
266,928
+21,387
| +9% | +$2.08M | 6.81% | 5 |
|
|
2015
Q1 | $23M | Buy |
245,541
+47,198
| +24% | +$4.41M | 6.14% | 6 |
|
|
2014
Q4 | $17.6M | Buy |
+198,343
| New | +$17.6M | 4.71% | 12 |
|